PRESS RELEASES
Archives
October 20, 2010 - New Data Show Therapeutic Benefits in Chronic Rhinosinusitis Patients Using Fluticasone Delivered by OptiNose’s Novel Delivery Technology
August 10, 2010 - OptiNose Announces Publication of Positive Subgroup Analysis Evaluating Efficacy of Fluticasone Delivered with Novel Drug Delivery Technology
June 7, 2010 - Avista Capital Partners Commits $48.5 Million to OptiNose to Develop an Innovative Nasal Drug Delivery Technology Slated to Begin Phase III Trials
December 1, 2009 - New Data on Highly Effective Treatment for Chronic Rhinosinusitis with Nasal Polyps
April 17, 2009 - Rhinology World 2009 Presentation
April 17, 2009 - Optinose Presents New Data on Highly Effective Treatment for Chronic Rhinosinusits
April 1, 2009 - Nasal Drug Delivery Conference Presentation
September 20, 2008 - American Rhinology Society Presentation
September 19, 2008 - OptiNose Presents Data On Highly Effective Nasal Polyp Treatment
June 28, 2008 - American Headache Society – Phase II Migraine (Poster PDF, 652KB)